ArticleFrontiers in surgery2026
Pulmonary vein stenosis after pediatric heart transplantation: incidence and risk factors.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Postoperative pulmonary vein stenosis (PVS) is an uncommon but potentially serious complication following pediatric heart transplantation. This study aimed to determine the prevalence of PVS and identify donor- and recipient-related predictors. Methods: We retrospectively reviewed pediatric patients (<18 years) who underwent heart transplantation at a single center between 2003 and 2024. PVS was defined as a ≥ 4 mmHg Doppler gradient across any pulmonary vein on echocardiography or significant narrowing on computed tomography. Donor and recipient variables-including congenital heart disease (CHD), predicted heart mass (PHM), donor-recipient size/sex were analyzed using univariate and multivariable logistic regression. The primary endpoint was the occurrence of PVS; the secondary endpoint was overall mortality. Results: Among 50 recipients (median age, 11 years; range, 0.2-17 years), 9 (18%) developed Conclusions: PVS occurred in nearly one-fifth of pediatric heart transplant recipients, predominantly in those with CHD. However, given the limited sample size, these findings should be considered exploratory and hypothesis-generating. Donor-recipient size mismatch parameters were consistently greater among patients with PVS, though this association warrants validation in larger prospective cohorts. Although PVS was not associated with increased mortality, identification of high-risk groups remains essential for surveillance and preventive strategies in pediatric heart transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.